Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 12 06 2019
accepted: 23 08 2019
entrez: 28 9 2019
pubmed: 29 9 2019
medline: 12 3 2020
Statut: epublish

Résumé

PCR inhibition is frequent in medical microbiology routine practice and may lead to false-negative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor detection using these two methods. We analysed Cp shifts (ΔCp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples including various matrixes were included. Pathogen-specific amplification and albumin qPCR identified 62/3152 samples (2.0%), and 409/3152 (13.0%) samples, respectively, as inhibited. Only 16 samples were detected using both methods. In addition, the use of the Youden's index failed to determine adequate Cp thresholds for albumin qPCR, even when we distinguished among the different sample matrixes. qPCR targeting the albumin gene therefore appears not adequate to identify the presence of PCR inhibitors in microbiological PCR assays. Our data may be extrapolated to other heterologous targets and should discourage their use to assess the presence of PCR inhibition in microbiological PCR assays.

Identifiants

pubmed: 31560697
doi: 10.1371/journal.pone.0219276
pii: PONE-D-19-16663
pmc: PMC6764677
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0219276

Déclaration de conflit d'intérêts

We acknowledge the financial support of the "RSI Assurance Maladie Professions Libérales - Provinces. C.A.M.P.L.P." for buying the LightCycler 480 (Roche®) real-time PCR equipment. Since this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; this does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

J Clin Microbiol. 2004 Apr;42(4):1719-22
pubmed: 15071031
Diagn Microbiol Infect Dis. 2014 Nov;80(3):197-9
pubmed: 25241642
J Clin Microbiol. 2014 Jun;52(6):2139-43
pubmed: 24740078
J Clin Microbiol. 1998 Jan;36(1):191-7
pubmed: 9431945
Methods Mol Biol. 2013;943:159-70
pubmed: 23104289
Front Microbiol. 2017 Feb 02;8:108
pubmed: 28210243
BMC Infect Dis. 2003 May 02;3:7
pubmed: 12729464
J Med Microbiol. 2011 Jul;60(Pt 7):937-44
pubmed: 21459903
Forensic Sci Int Genet. 2014 Mar;9:55-60
pubmed: 24528580
Methods Mol Biol. 2013;943:49-79
pubmed: 23104281
N Engl J Med. 1994 Sep 15;331(11):695-9
pubmed: 8058075
Clin Chem. 1981 Mar;27(3):493-501
pubmed: 7471403
J Clin Microbiol. 2012 Dec;50(12):3944-51
pubmed: 23035201
J Clin Microbiol. 2014 Nov;52(11):3952-9
pubmed: 25187637
Methods Mol Biol. 2013;943:17-48
pubmed: 23104280
Parasite. 2007 Jun;14(2):149-54
pubmed: 17645187
Pathol Biol (Paris). 2010 Feb;58(1):104-9
pubmed: 19892493
FEMS Immunol Med Microbiol. 2006 Nov;48(2):183-91
pubmed: 17064275
J Clin Microbiol. 2004 Nov;42(11):5249-55
pubmed: 15528722
BMC Res Notes. 2008 Aug 28;1:70
pubmed: 18755023
J Clin Microbiol. 2001 Feb;39(2):485-93
pubmed: 11158094
Clin Microbiol Infect. 2010 Oct;16(10):1594-602
pubmed: 19886905
J Appl Microbiol. 2012 Nov;113(5):1014-26
pubmed: 22747964
BMC Mol Biol. 2010 Sep 21;11:74
pubmed: 20858237

Auteurs

Guillaume Roux (G)

Univ. Montpellier, and Laboratoire de Microbiologie, Centre Hospitalier Universitaire (CHU) of Nîmes, Nîmes, France.

Christophe Ravel (C)

Univ. Montpellier, Centre Hospitalier Universitaire (CHU) of Montpellier, Dept. of Parasitology-Mycology, Research Unit MiVEGEC, CNRS, IRD, Montpellier, France.

Emmanuelle Varlet-Marie (E)

Univ. Montpellier, Centre Hospitalier Universitaire (CHU) of Montpellier, Dept. of Parasitology-Mycology, Research Unit MiVEGEC, CNRS, IRD, Montpellier, France.

Rachel Jendrowiak (R)

Univ. Montpellier, Centre Hospitalier Universitaire (CHU) of Montpellier, Dept. of Parasitology-Mycology, Research Unit MiVEGEC, CNRS, IRD, Montpellier, France.

Patrick Bastien (P)

Univ. Montpellier, Centre Hospitalier Universitaire (CHU) of Montpellier, Dept. of Parasitology-Mycology, Research Unit MiVEGEC, CNRS, IRD, Montpellier, France.

Yvon Sterkers (Y)

Univ. Montpellier, Centre Hospitalier Universitaire (CHU) of Montpellier, Dept. of Parasitology-Mycology, Research Unit MiVEGEC, CNRS, IRD, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH